Importantly, paclitaxel prevented LPS-induced AKI by regulating the MALAT1/miR-370-3p/HMGB1 axis, indicating that paclitaxel may serve as a therapeutic agent to mitigate SA-AKI. This evidence concerns the gene HMGB1 and acute kidney injury.